Related references
Note: Only part of the references are listed.Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death
I. Obiorah et al.
BRITISH JOURNAL OF CANCER (2014)
Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
Hiltrud Brauch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes
Philipp Y. Maximov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Breast Cancer Cell Apoptosis with Phytoestrogens Is Dependent on an Estrogen-Deprived State
Ifeyinwa E. Obiorah et al.
CANCER PREVENTION RESEARCH (2014)
Molecular Modulation of Estrogen-Induced Apoptosis by Synthetic Progestins in Hormone Replacement Therapy: An Insight into the Women's Health Initiative Study
Elizabeth E. Sweeney et al.
CANCER RESEARCH (2014)
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
V. Craig Jordan
ENDOCRINE-RELATED CANCER (2014)
Identification of gene regulation patterns underlying both oestrogen-and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2014)
A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2014)
Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2014)
Past, Present, and Future Challenges in Breast Cancer Treatment
George W. Sledge et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Influence of the Length and Positioning of the Antiestrogenic Side Chain of Endoxifen and 4-Hydroxytamoxifen on Gene Activation and Growth of Estrogen Receptor Positive Cancer Cells
Philipp Y. Maximov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pharmacological Relevance of Endoxifen in a Laboratory Simulation of Breast Cancer in Postmenopausal Patients
Philipp Y. Maximov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Linking Estrogen-Induced Apoptosis With Decreases in Mortality Following Long-term Adjuvant Tamoxifen Therapy
V. Craig Jordan
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The Effects of Soy Supplementation on Gene Expression in Breast Cancer: A Randomized Placebo-Controlled Study
Moshe Shike et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Avoiding the Bad and Enhancing the Good of Soy Supplements in Breast Cancer
V. Craig Jordan
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer
Mary Ellen Molloy et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A(nother) scientific strategy to prevent breast cancer in postmenopausal women by enhancing estrogen-induced apoptosis?
V. Craig Jordan
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2014)
Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations
Ping Fan et al.
STEROIDS (2014)
Selective estrogen-induced apoptosis in breast cancer
Ifeyinwa E. Obiorah et al.
STEROIDS (2014)
Defining the Conformation of the Estrogen Receptor Complex That Controls Estrogen-Induced Apoptosis in Breast Cancer
Ifeyinwa Obiorah et al.
MOLECULAR PHARMACOLOGY (2014)
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells
S. Sengupta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Prostate circulating tumor cells metastasize to bone via E-selectin expressed on endothelial cells.
Gunjan Gakhar et al.
CANCER RESEARCH (2013)
c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells
Ping Fan et al.
CANCER RESEARCH (2013)
Bazedoxifene Exhibits Antiestrogenic Activity in Animal Models of Tamoxifen-Resistant Breast Cancer: Implications for Treatment of Advanced Disease
Suzanne E. Wardell et al.
CLINICAL CANCER RESEARCH (2013)
被撤回的出版物: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer (Retracted article. See vol. 16, 2017)
Bethany Perez White et al.
MOLECULAR CANCER (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells
Aurelie Courtin et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mouse keratinocyte side-population plays an important role during malignant progression to skin squamous cell carcinomas
Sun Hye Kim et al.
CANCER RESEARCH (2012)
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2012)
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
Jonas Bergh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
CBP Mediates NF-kappa B-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter
Madhumita Pradhan et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
Garnet L. Anderson et al.
LANCET ONCOLOGY (2012)
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
Rita S. Mehta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Paradoxical Clinical Effect of Estrogen on Breast Cancer Risk: A New Biology of Estrogen-induced Apoptosis
V. Craig Jordan et al.
CANCER PREVENTION RESEARCH (2011)
Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial
Andrea Z. LaCroix et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Valerie Beral et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
C. Davies et al.
LANCET (2011)
The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
Marc A. Becker et al.
MOLECULAR ENDOCRINOLOGY (2011)
The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1
Joan S. Lewis-Wambi et al.
MOLECULAR PHARMACOLOGY (2011)
Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells
Zhang-Zhi Hu et al.
PLOS ONE (2011)
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
Eric A. Ariazi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells
Sandrine Bourgoin-Voillard et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2010)
Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study
Matthew J. Ellis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Potential of L-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer
Joan S. Lewis-Wambi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Estradiol-Induced Regression in T47D:A18/PKC alpha Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix
Yiyun Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
Joan S. Lewis-Wambi et al.
BREAST CANCER RESEARCH (2009)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
Tamoxifen: Catalyst for the change to targeted therapy
V. Craig Jordan
EUROPEAN JOURNAL OF CANCER (2008)
The 38th David A. Karnofsky lecture: The paradoxical actions of estrogen in breast cancer - Survival or death?
V. Craig Jordan
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
Joan S. Lewis-Wambi et al.
BREAST CANCER RESEARCH (2008)
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer
J. W. Assender et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Protein kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells
Lisa B. Frankel et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer
Isabel Chu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
Jack Cuzick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Twenty-year follow-up of the royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
Trevor J. Powles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
V. Craig Jordan et al.
STEROIDS (2007)
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer
Suleiman Massarweh et al.
CANCER RESEARCH (2006)
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action
WR Harrington et al.
MOLECULAR ENDOCRINOLOGY (2006)
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation
JS Lewis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Synthetic progestins used in HRT have different glucocorticoid agonist properties
D Koubovec et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER+ breast cancer cells
RXD Song et al.
APOPTOSIS (2005)
Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
SM Nabha et al.
ONCOGENE (2005)
Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy
C Osipo et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal
JS Lewis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Targeting oestrogen to kill the cancer but not the patient
JS Lewis et al.
BRITISH JOURNAL OF CANCER (2004)
Selective estrogen receptor modulation: Concept and consequences in cancer
VC Jordan
CANCER CELL (2004)
Apoptotic action of 17β-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo
H Liu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer
C Osipo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents
VC Jordan
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions
VC Jordan
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Apoptotic action of estrogen
RXD Song et al.
APOPTOSIS (2003)
Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes
V Lubczyk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Double-blind, Randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trial
CK Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Structure-function relationships of the raloxifene-estrogen receptor-α complex for regulating transforming growth factor-α expression in breast cancer cells
H Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17β-estradiol
RXD Song et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: Possible role in AP-1-mediated proliferation of ER-negative endometrial cancer
DB Fournier et al.
GYNECOLOGIC ONCOLOGY (2001)
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy
PE Lonning et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
YF Shang et al.
CELL (2000)
Stable transfection of protein kinase C alpha cDNA in hormone dependent breast cancer cell lines
DA Tonetti et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
